Year: 2016

His new job involves worldwide health innovation. “I think why they are engaging me is the messaging,” Evans told Matt Galloway on CBC’s Metro … […]

The new investigator fund at Hamilton Health Sciences is footing the $50,000 bill to do the study on the increasingly common disease in children … […]

Merck & Co Inc (NYSE:MRK) and Pfizer Inc (NYSE:PFE) will launch a new oral diabetes treatment in the US by the end of this year after it passed a … […]

It’s a curious case of missing evidence. When a diabetes specialist searched the medical literature looking for proof to support the use of … […]

Children may be more vulnerable to the effects of toxic chemicals because their brains and bodies are still developing, according to the research. […]

Two Simon Fraser University professors are close to realizing their vision of a new data-sharing resource for the immune genetics research community … […]

Sept. 15, 2016 /CNW/ – Sanofi announced today the key results of a new pharmacokinetic / pharmacodynamic (PK/PD) study in people with type 1 diabetes comparing Toujeo® (insulin glargine 300 Units/mL) to insulin degludec U100. […]

Before Sanofi Pasteur distributed its dengue vaccine, Dengvaxia, there were some concerns that it would actually make people sicker. A new study … […]

… Matthew J. Oliver, MD, of Sunnybrook Health Sciences Centre in Toronto, and colleagues compared hospitalization rates associated with assisted … […]

“It’s underwhelming,” said Dr. David Juurlink, a drug safety researcher with Sunnybrook Health Sciences Centre. “It’s difficult to argue that any of the … […]